Can you drink alcohol while taking Skyrizi?
Skyrizi (risankizumab-rzaa) is a medication used to treat adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy, as well as adults with active psoriatic arthritis or moderately-to-severely active ulcerative colitis or Crohn's disease. Skyrizi is not known to interact with alcohol and there is no warning in the Skyrizi Package Insert against drinking alcohol while receiving Skyrizi.
While drinking alcohol isn’t contraindicated while Skyrizi is being used as a treatment, alcohol consumption is known to be higher in people with psoriasis than the general population and drinking alcohol can worsen the symptoms of psoriasis. People with psoriasis may benefit from limiting or avoiding alcohol. Alcohol consumptions should also be limited or avoided in people with ulcerative colitis or Crohn's disease if if causes symptoms to flare up.
References
- Skyrizi Prescribing Information. Revised 06/2024. AbbVie Inc. https://www.rxabbvie.com/pdf/skyrizi_pi.pdf
- Skyrizi Package Insert. Revised 06/2024. AbbVie Inc. https://www.rxabbvie.com/pdf/skyrizi_medguide.pdf
- Brenaut E, Horreau C, Pouplard C, et al. Alcohol consumption and psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2013;27 Suppl 3:30-35. doi:10.1111/jdv.12164.
- Szentkereszty-Kovács Z, Gáspár K, Szegedi A, Kemény L, Kovács D, Törőcsik D. Alcohol in Psoriasis-From Bench to Bedside. Int J Mol Sci. 2021;22(9):4987. Published 2021 May 7. doi:10.3390/ijms22094987.
- Piovezani Ramos G, Kane S. Alcohol Use in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2021;17(5):211-225.
- FDA Approves Skyrizi (risankizumab-rzaa) for Ulcerative Colitis. June 18, 2024. Drugs.com https://www.drugs.com/newdrugs/fda-approves-skyrizi-risankizumab-rzaa-ulcerative-colitis-6307.html
Read next
What are Monoclonal Antibodies and how do they work?
Monoclonal antibodies (mAbs) are man-made proteins that mimic the natural antibodies produced by our immune systems. Monoclonal antibodies can be formulated into medicines to treat various types of illnesses, such as cancer, rheumatoid arthritis or psoriasis.
Continue reading
What are IL-23 Inhibitors and how do they work?
IL-23 inhibitors represent a class of biologic medications that target interleukin-23 (IL-23), a key inflammatory cytokine that plays a central role in driving immune system dysfunction.
Continue reading
What's the dosing schedule for Skyrizi?
After your initial starter doses, you'll receive Skyrizi as subcutaneous (under the skin) maintenance dose every 12 weeks (4 times per year) to treat either plaque psoriasis or psoriatic arthritis, or every 8 weeks (6 times per year) to treat either Crohn's disease or ulcerative colitis. You can self-administer these injections at home after proper training from your healthcare provider. Continue reading
See also:
Related medical questions
- Does Skyrizi cause cancer?
- Who makes Skyrizi and where is it made?
- Skyrizi vs Humira for plaque psoriasis - How do they compare?
- Is Omvoh the same as Skyrizi?
- Does Skyrizi cause hair loss?
- Is Skyrizi approved for treating psoriatic arthritis?
- Skyrizi vs Ilumya. What’s the difference?
- What are the new drugs for plaque psoriasis?
- How long does it take for Skyrizi to work?
- What causes Plaque Psoriasis?
- Who sings the Skyrizi song ‘Nothing is everything’?
- How does Skyrizi work (MOA)?
- How is Skyrizi injection administered?
Drug information
- Skyrizi Information for Consumers
- Skyrizi prescribing info & package insert (for Health Professionals)
- Side Effects of Skyrizi (detailed)
- Skyrizi user reviews (67)
Related support groups
- Skyrizi (19 questions, 9 members)
- Plaque Psoriasis (92 questions, 69 members)
- Psoriatic Arthritis (90 questions, 282 members)